SG11201708356PA - Penicillin-g acylases - Google Patents

Penicillin-g acylases

Info

Publication number
SG11201708356PA
SG11201708356PA SG11201708356PA SG11201708356PA SG11201708356PA SG 11201708356P A SG11201708356P A SG 11201708356PA SG 11201708356P A SG11201708356P A SG 11201708356PA SG 11201708356P A SG11201708356P A SG 11201708356PA SG 11201708356P A SG11201708356P A SG 11201708356PA
Authority
SG
Singapore
Prior art keywords
acylases
penicillin
Prior art date
Application number
SG11201708356PA
Inventor
Goutami Banerjee
Jie Yang
Xiyun Zhang
Erika M Milczek
Melissa Ann Mayo
Stephan Jenne
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of SG11201708356PA publication Critical patent/SG11201708356PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/84Penicillin amidase (3.5.1.11)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01011Penicillin amidase (3.5.1.11), i.e. penicillin-amidohydrolase
SG11201708356PA 2015-05-07 2016-05-06 Penicillin-g acylases SG11201708356PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562158118P 2015-05-07 2015-05-07
PCT/US2016/031132 WO2016179464A1 (en) 2015-05-07 2016-05-06 Penicillin-g acylases

Publications (1)

Publication Number Publication Date
SG11201708356PA true SG11201708356PA (en) 2017-11-29

Family

ID=57218075

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201708356PA SG11201708356PA (en) 2015-05-07 2016-05-06 Penicillin-g acylases

Country Status (14)

Country Link
US (5) US9944916B2 (en)
EP (1) EP3292136B1 (en)
JP (1) JP6755886B2 (en)
KR (1) KR102604503B1 (en)
CN (1) CN107531762A (en)
AU (1) AU2016258091B2 (en)
CA (1) CA2983620A1 (en)
DK (1) DK3292136T3 (en)
HU (1) HUE053863T2 (en)
IL (1) IL255245B (en)
MX (1) MX2017014213A (en)
NZ (1) NZ736220A (en)
SG (1) SG11201708356PA (en)
WO (1) WO2016179464A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3292136B1 (en) 2015-05-07 2021-02-17 Codexis, Inc. Penicillin-g acylases
KR102382489B1 (en) 2016-05-05 2022-04-01 코덱시스, 인코포레이티드 Penicillin G acylase
AU2018205718B2 (en) * 2017-01-05 2023-09-28 Codexis, Inc. Penicillin-G acylases
EP3645713A4 (en) * 2017-06-27 2021-06-30 Codexis, Inc. Penicillin-g acylases
KR101985911B1 (en) * 2017-12-28 2019-06-04 아미코젠주식회사 Mutants of penicillin G acylase from Achromobacter sp. CCM 4824, and uses thereof
CN109207466B (en) * 2018-11-08 2021-01-08 山东鲁抗医药股份有限公司 Immobilization method of penicillin acylase and immobilized enzyme
KR102363768B1 (en) * 2019-11-15 2022-02-16 아미코젠주식회사 Mutants of penicillin G acylase with increased production of cefazolin, and uses thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603344A (en) 1898-05-03 Trough for well-curbs
CA1338400C (en) 1983-08-31 1996-06-18 David H. Gelfand Recombinant fungal cellulases
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
ES2165420T3 (en) 1994-06-03 2002-03-16 Novozymes Biotech Inc MYCELIOPHTHORA PURIFIED LACQUES AND NUCLEIC ACIDS THAT CODE THEM.
CN101659926A (en) 1994-06-30 2010-03-03 诺沃奇梅兹有限公司 Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
JP4147319B2 (en) * 1994-08-12 2008-09-10 コニンクリーケ デーエスエム ナムローゼ フェンノートシャップ Mutant penicillin G acylase gene
FI104465B (en) 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
CA2276064C (en) 1997-01-17 2013-12-17 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
DK1117808T3 (en) 1998-10-06 2005-04-25 Mark Aaron Emalfarb Transformational system before comparing the area of filamentous fungal hosts: In the chrysosporium
JP4221100B2 (en) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 Semiconductor device
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
AU3210200A (en) 1999-01-19 2000-08-01 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6365377B1 (en) 1999-03-05 2002-04-02 Maxygen, Inc. Recombination of insertion modified nucleic acids
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
AU4964101A (en) 2000-03-30 2001-10-15 Maxygen Inc In silico cross-over site selection
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7783428B2 (en) 2002-03-01 2010-08-24 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
SI1648933T1 (en) 2003-07-25 2010-01-29 Conjuchem Biotechnologies Inc Long lasting insulin derivatives and methods thereof
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
CA2726850C (en) 2008-06-13 2015-06-02 Codexis, Inc. Method of synthesizing polynucleotide variants
WO2010054319A2 (en) * 2008-11-10 2010-05-14 Codexis, Inc. Penicillin-g acylases
MX2011006802A (en) * 2008-12-23 2011-07-20 Dsm Ip Assets Bv Mutant penicillin g acylases.
CN103074320B (en) * 2012-05-25 2018-06-08 石药集团中奇制药技术(石家庄)有限公司 Penicillin G acylase containing one or several point mutation
EP3292136B1 (en) 2015-05-07 2021-02-17 Codexis, Inc. Penicillin-g acylases

Also Published As

Publication number Publication date
US20200385699A1 (en) 2020-12-10
US9944916B2 (en) 2018-04-17
US20220042004A1 (en) 2022-02-10
US20190345474A1 (en) 2019-11-14
JP6755886B2 (en) 2020-09-16
WO2016179464A1 (en) 2016-11-10
IL255245A0 (en) 2017-12-31
MX2017014213A (en) 2018-03-28
CA2983620A1 (en) 2016-11-10
NZ736220A (en) 2024-03-22
EP3292136A4 (en) 2019-04-10
JP2018515089A (en) 2018-06-14
US10400231B2 (en) 2019-09-03
AU2016258091A1 (en) 2017-11-02
KR20180004169A (en) 2018-01-10
US20160326508A1 (en) 2016-11-10
DK3292136T3 (en) 2021-03-22
EP3292136B1 (en) 2021-02-17
CN107531762A (en) 2018-01-02
US10781436B2 (en) 2020-09-22
EP3292136A1 (en) 2018-03-14
US20180201919A1 (en) 2018-07-19
IL255245B (en) 2020-03-31
KR102604503B1 (en) 2023-11-20
AU2016258091B2 (en) 2020-10-01
HUE053863T2 (en) 2021-07-28
US11180747B2 (en) 2021-11-23

Similar Documents

Publication Publication Date Title
IL248312A0 (en) Suspension element
PL3417725T3 (en) Hookah
GB201520799D0 (en) None
GB201413050D0 (en) None
GB201516266D0 (en) None
PL3188641T3 (en) Holding assembly
GB2538731B (en) Methods
IL255245A0 (en) Penicillin-g acylases
GB201516146D0 (en) None
GB201518762D0 (en) Methods
GB201403223D0 (en) Coated glazing
GB201508927D0 (en) Methods
IL267768A (en) Penicillin-g acylases
IL262550B (en) Penicillin-g acylases
GB201515655D0 (en) Methods
HK1250866A1 (en) Connection configuration
PL2902575T3 (en) Fitting configuration
PT3420078T (en) Beta-lactamase variants
IL271505A (en) Penicillin-G Acylases
SG11201804610RA (en) Marking-out aid
GB201512609D0 (en) Methods
GB201501597D0 (en) Thrombomodulin
GB2522661B (en) Context configuration
GB201409138D0 (en) None
GB2557903B (en) Suspension element